Glycobiology Research and Training Center, University of California San Diego, La Jolla, CA 92093.
Department of Cellular & Molecular Medicine, University of California San Diego, La Jolla, CA 92093.
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16036-16045. doi: 10.1073/pnas.1902902116. Epub 2019 Jul 22.
Cardiovascular disease (CVD) events due to atherosclerosis cause one-third of worldwide deaths and risk factors include physical inactivity, age, dyslipidemia, hypertension, diabetes, obesity, smoking, and red meat consumption. However, ∼15% of first-time events occur without such factors. In contrast, coronary events are extremely rare even in closely related chimpanzees in captivity, despite human-like CVD-risk-prone blood lipid profiles, hypertension, and mild atherosclerosis. Similarly, red meat-associated enhancement of CVD event risk does not seem to occur in other carnivorous mammals. Thus, heightened CVD risk may be intrinsic to humans, and genetic changes during our evolution need consideration. Humans exhibit a species-specific deficiency of the sialic acid -glycolylneuraminic acid (Neu5Gc), due to pseudogenization of cytidine monophosphate--acetylneuraminic acid (Neu5Ac) hydroxylase ( which occurred in hominin ancestors ∼2 to 3 Mya. mice with human-like deficiency fed a sialic acids (Sias)-free high-fat diet (HFD) showed ∼1.9-fold increased atherogenesis over wild-type mice, associated with elevated macrophage cytokine expression and enhanced hyperglycemia. Human consumption of Neu5Gc (from red meat) acts as a "xeno-autoantigen" via metabolic incorporation into endogenous glycoconjugates, as interactions with circulating anti-Neu5Gc "xeno-autoantibodies" potentiate chronic inflammation ("xenosialitis"). mice immunized with Neu5Gc-bearing antigens to generate human-like anti-Neu5Gc antibodies suffered a ∼2.4-fold increased atherosclerosis on a Neu5Gc-rich HFD, compared with Neu5Ac-rich or Sias-free HFD. Lesions in Neu5Gc-immunized and Neu5Gc-rich HFD-fed mice were more advanced but unexplained by lipoprotein or glucose changes. Human evolutionary loss of CMAH likely contributes to atherosclerosis predisposition via multiple intrinsic and extrinsic mechanisms, and future studies could consider this more human-like model.
心血管疾病(CVD)事件归因于动脉粥样硬化,导致全球三分之一的死亡,其风险因素包括身体活动不足、年龄、血脂异常、高血压、糖尿病、肥胖、吸烟和食用红肉。然而,约 15%的首次发病没有这些因素。相比之下,即使在圈养的与人类密切相关的黑猩猩中,也很少发生冠状动脉事件,尽管它们的血液脂质谱、高血压和轻度动脉粥样硬化与人类的 CVD 风险倾向相似。同样,在其他肉食性哺乳动物中,似乎也不会发生与食用红肉相关的 CVD 发病风险增加。因此,CVD 风险增加可能是人类特有的,需要考虑我们在进化过程中的遗传变化。人类表现出唾液酸 -N- 乙酰神经氨酸(Neu5Gc)的种特异性缺乏,这是由于胞苷单磷酸-N-乙酰神经氨酸(Neu5Ac)羟化酶在人类祖先约 2 到 300 万年前发生假基因化所致。用与人相似的缺乏唾液酸的高脂肪饮食(HFD)喂养的 Neu5Gc 缺乏的小鼠比野生型小鼠的动脉粥样硬化形成增加了约 1.9 倍,与巨噬细胞细胞因子表达升高和高血糖增强有关。人类摄入 Neu5Gc(来自红肉)作为一种“异源自身抗原”,通过代谢掺入内源性糖缀合物,与循环抗-Neu5Gc“异源自身抗体”相互作用增强慢性炎症(“异源唾液炎”)。用 Neu5Gc 结合抗原免疫小鼠以产生与人相似的抗-Neu5Gc 抗体,与 Neu5Ac 丰富或无唾液酸的 HFD 相比,在富含 Neu5Gc 的 HFD 上的动脉粥样硬化增加了约 2.4 倍。Neu5Gc 免疫和 Neu5Gc 丰富的 HFD 喂养的小鼠的病变更严重,但脂蛋白或葡萄糖变化无法解释。人类 CMAH 的进化缺失可能通过多种内在和外在机制导致动脉粥样硬化易感性,未来的研究可以考虑这种更像人类的模型。